-
Mashup Score: 137Hepatorenal Syndrome in Cirrhosis - 5 day(s) ago
Hepatorenal syndrome (HRS) is a form of kidney dysfunction that characteristically occurs in liver cirrhosis. It is characterized by a marked impairment of kidney function in response to circulatory and hemodynamic alterations that occur in advanced stages of liver cirrhosis, aggravated by systemic inflammation and bacterial translocation. The classical definitions of the types of HRS have been recently revisited and 2 forms of HRS have been redefined: the acute form, referred to as acute kidney injury (HRS-AKI), and the chronic form, referred to as chronic kidney disease.
Source: www.gastrojournal.orgCategories: General Medicine News, GastroenterologyTweet
-
Mashup Score: 0
Patients with cirrhosis had greater health care costs than matched controls, attributed mostly to cirrhosis complications and high inpatient utilization in the first year after diagnosis.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
A retrospective study found patients with #cirrhosis had greater health care costs than matched controls, attributed mostly to cirrhosis-related complications and increased inpatient utilization in the first year after diagnosis. https://t.co/hSnQ40Uznr
-
-
Mashup Score: 0
Patients with cirrhosis had greater health care costs than matched controls, attributed mostly to cirrhosis complications and high inpatient utilization in the first year after diagnosis.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet-
A retrospective study found patients with #cirrhosis had greater health care costs than matched controls, attributed mostly to cirrhosis-related complications and increased inpatient utilization in the first year after diagnosis. https://t.co/hSnQ40Uznr
-
-
Mashup Score: 0
Heavy binge drinking and high polygenic risk score were associated with a sixfold higher relative excess risk for alcohol-related cirrhosis, with the presence of diabetes mellitus further increasing the risk, researchers reported. “Many studies that look into the relationship between liver disease and alcohol focus on the volume of alcohol consumed,” Linda Ng Fat, MSc, PhD, senior
Source: www.healio.comCategories: General Medicine News, GastroenterologyTweet-
🚨BREAKING NEWS from @NatureComms🚨 Heavy binge drinking 🍺 and high polygenic risk 🧬 score were associated with a sixfold higher relative excess risk for alcohol-related #cirrhosis. Learn more 👇🏼 https://t.co/Lo41J4vk1B
-
-
Mashup Score: 0Recovery From Dialysis-Treated Acute Kidney Injury in Patients With Cirrhosis: A Population-Based Study - 7 month(s) ago
The decision to initiate kidney replacement therapy (KRT) for acute kidney injury (AKI) in cirrhosis remains controversial because it is unclear which patients will benefit. We sought to characterize factors associated with recovery from KRT-treated AKI in patients with cirrhosis to inform shared clinical decision-making.
Source: www.ajkd.orgCategories: Latest Headlines, NephrologyTweet-
Recovery From Dialysis-Treated Acute Kidney Injury in Patients With Cirrhosis https://t.co/P4YFNWDDWu (FREE temporarily) @lw_peter @drsamsilver @thana_susan @SashaZarnke @Jenn_Flemming @queensuDOM @ICESOntario #AKI #cirrhosis #dialysis #visualabstract https://t.co/ebtv5dd08P
-
-
Mashup Score: 2
Considering-disease-stage-and-indications-for-treatment-allows-for-more-personalized-recommendations-for-use-of-beta-blockers-for-bleeding-prevention-in-patients-with-cirrhosis-according-to-a-recent-literature-review
Source: www.gastroendonews.comCategories: Gastroenterology, Latest HeadlinesTweet-
Considering disease stage and indications for treatment allows for more personalized recommendations for use of beta blockers in patients with cirrhosis, experts say. #Hepatology #cirrhosis #NSBBs #CSPH #liverhealth @DrAAlbillos @AleksanderKrag https://t.co/W76sGEiBZC
-
-
Mashup Score: 22Suboptimal diagnostic accuracy of ultrasound and CT for... : Hepatology Communications - 8 month(s) ago
patients with various liver diseases were included. All patients were included between 2017 and 2022 and had undergone a liver biopsy as well as US and/or CT. Using the histological assessment as the gold standard, we calculated diagnostic accuracy for US and CT. Liver biopsies were evaluated by expert histopathologists and diagnostic scans by experienced radiologists. Results: The mean age was 54 ± 14 years and 47% were female. Most patients had NAFLD (58.3%) or alcohol-associated liver disease (25.5%). The liver biopsy showed cirrhosis in 147 patients (39.0%). Eighty-three patients with cirrhosis had Child-Pugh A (56.4% of patients with cirrhosis) and 64 had Child-Pugh B/C (43.6%). Overall, the sensitivity for diagnosing cirrhosis by US was 0.71 (95% CI 0.62–0.79) and for CT 0.74 (95% CI 0.64–0.83). The specificity was high for US (0.94, 95% CI 0.90–0.97) and for CT (0.93, 95% CI 0.83–0.98). When evaluating patients with Child-Pugh A cirrhosis, sensitivity was only 0.62 (95% CI 0.49–
Source: journals.lww.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
RT @ebtapper: Pssst. Ultrasound and CT scan are not sensitive for #cirrhosis Pass it on https://t.co/qhyWrIt3TP Open access in @HepComm…
-
-
Mashup Score: 14Suboptimal diagnostic accuracy of ultrasound and CT for... : Hepatology Communications - 8 month(s) ago
patients with various liver diseases were included. All patients were included between 2017 and 2022 and had undergone a liver biopsy as well as US and/or CT. Using the histological assessment as the gold standard, we calculated diagnostic accuracy for US and CT. Liver biopsies were evaluated by expert histopathologists and diagnostic scans by experienced radiologists. Results: The mean age was 54 ± 14 years and 47% were female. Most patients had NAFLD (58.3%) or alcohol-associated liver disease (25.5%). The liver biopsy showed cirrhosis in 147 patients (39.0%). Eighty-three patients with cirrhosis had Child-Pugh A (56.4% of patients with cirrhosis) and 64 had Child-Pugh B/C (43.6%). Overall, the sensitivity for diagnosing cirrhosis by US was 0.71 (95% CI 0.62–0.79) and for CT 0.74 (95% CI 0.64–0.83). The specificity was high for US (0.94, 95% CI 0.90–0.97) and for CT (0.93, 95% CI 0.83–0.98). When evaluating patients with Child-Pugh A cirrhosis, sensitivity was only 0.62 (95% CI 0.49–
Source: journals.lww.comCategories: Hem/Oncs, Latest HeadlinesTweet-
RT @ebtapper: Pssst. Ultrasound and CT scan are not sensitive for #cirrhosis Pass it on https://t.co/qhyWrIt3TP Open access in @HepComm…
-
-
Mashup Score: 0Archita Desai on a New Tool to Monitor Cirrhosis Patients - 8 month(s) ago
Liver cirrhosis imposes a growing economic burden on the U.S. .
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
ICYMI: Did you work from an assumption that such an instrument would be effective for monitoring these aspects in #cirrhosis patients? #AGAReadingRoom @AmerGastroAssn #Gastroenterology Read more: https://t.co/EEsXzah5sw https://t.co/5sQCxBuQKF
-
-
Mashup Score: 0
AbstractBackground:. Hepatocellular carcinoma (HCC) surveillance is underutilized, with <25% of individuals with cirrhosis receiving surveillance exams as recommended. The epidemiology of cirrhosis and HCC in the United States has also shifted in recent years, but little is known about recent trends in surveillance utilization. We characterized patterns of HCC surveillance by payer, cirrhosis etiology, and calendar year in insured individuals with cirrhosis.Methods:. We conducted a retrospective cohort study of individuals with cirrhosis using claims data from Medicare, Medicaid, and private insurance plans in North Carolina. We included individuals ≥ 18 years with a first occurrence of an ICD-9/10 code for cirrhosis between January 1, 2010, and June 30, 2018. The outcome was HCC surveillance by abdominal ultrasound, CT, or MRI. We estimated 1- and 2-year cumulative incidences for HCC surveillance and assessed longitudinal adherence to surveillance by computing the proportion of time c
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI: Authors study HCC surveillance by payer, #cirrhosis etiology and calendar year in insured individuals with cirrhosis and find HCC surveillance initiation after diagnosis remains low although slightly improved over time. https://t.co/qvmOYuh4Dn #HepatocellularCarcinoma https://t.co/4p0zkg1sSD
-
Hepatorenal Syndrome in #Cirrhosis ➡️ https://t.co/YbGpSVP8mP https://t.co/lyg88sRVm3